A

Avadel Pharmaceuticals-adr (AVDL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Avadel Pharmaceuticals-adr (AVDL)

Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more

  • USD8.11
  • USD8.52
  • USD8.00
  • USD10.20
  • -7.60%
  • --
  • 5.40M
  • 390.11k
  • 583M
  • 1.05
  • 35.70%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.